Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterology 2021 March;67(1) > Minerva Gastroenterology 2021 March;67(1):79-90

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Gastroenterology 2021 March;67(1):79-90

DOI: 10.23736/S2724-5985.20.02726-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Rheumatic manifestations in inflammatory bowel disease

Annacarla FINUCCI , Maria Chiara DITTO, Simone PARISI, Richard BORRELLI, Marta PRIORA, Cristina REALMUTO, Enrico FUSARO

Unit of Rheumatology, Città della Salute e della Scienza, Turin, Italy



Rheumatic manifestations are the most frequent extra-intestinal manifestations (EIMs) in inflammatory bowel disease (IBD) patients, and they are responsible for a relevant reduction of quality of life. IBD is associated with a variety of musculoskeletal manifestations such as arthritis and non-inflammatory pain as well as with metabolic diseases, such as osteoporosis. Different imaging techniques (primarily ultrasound, magnetic resonance imaging and X-rays) can help the clinician to correctly identify the nature of manifestations and to treat the patient accordingly. Nowadays, in the setting of IBD-related arthritides, different drugs are available and can be effective on both articular and intestinal involvement. Therefore, a multi-disciplinary approach provides an early diagnosis and a better clinical outcome that can only be given from the recognition and consideration of the different EIMs. As for rheumatic manifestations, namely IBD-related arthritis, an early intervention allows to control disease activity and to prevent structural damage.


KEY WORDS: Inflammatory bowel diseases; Spondyloarthritis; Arthritis

top of page